Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

Blood (2019) 134 (Supplement_1): 2887.

https://doi.org/10.1182/blood-2019-129532

Published: 2019

Journal Articles

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Emel Unal, Derya Ozyoruk, Nurdan Tacyildiz, Ferda Pi̇narli̇, A Erdogan, S Hanalioglu, Arzu Erdem, Meral Beksac, MD

Blood (2019) 134 (Supplement_1): 5632.

https://doi.org/10.1182/blood-2019-130102

Published: 2019

Journal Articles

A Two-Site Interaction Underpins TRIM25 Activation of the RIG-I Anti-Viral Response

Akshay A D'Cruz, Nadia J Kershaw, Edmond M Linossi, Jessica J Chiang, May K Wang, Laura F Dagley, Ben A Croker, Jian-Guo Zhang, Michaela U Gack, Nicos A Nicola, Jeffrey J Babon, Sandra E Nicholson

Blood (2014) 124 (21): 1580.

https://doi.org/10.1182/blood.V124.21.1580.1580

Published: 2014

Journal Articles

Response Of Rare Variants Of Cutaneous T Cell Lymphoma (CTCL) To Treatment With Bexarotene. A Prospective German DeCOG Trial

Blood (2013) 122 (21): 4379.

https://doi.org/10.1182/blood.V122.21.4379.4379

Published: 2013

Journal Articles

Mutations in the TNFRSF1A, CEBPE and ELANE genes in a Congenital Cyclic Neutropenia Patient: A New Syndrome?

Julia Skokowa, MD, PhD, Olga Klimenkova, Maksim Klimiankou, Siarhei Kandabarau, Marlene Reuter, Anna-Lena Hagemann, Karl Welte, MD

Blood (2012) 120 (21): 11.

https://doi.org/10.1182/blood.V120.21.11.11

Published: 2012

Journal Articles

Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL.

Xiaowei Zhang, Xiaojing Yan, Feifei Yang, Ziren Zhou, Ziyu Wu, Hongbin Sun, Wenxue Liang, Aixin Song, Qiuhua Huang, Guangbiao Zhou, Jianhua Tong, Yan Zhang, Jihui Wu, Hongyu Hu, Saijuan Chen, Zhu Chen

Blood (2009) 114 (22): 592.

https://doi.org/10.1182/blood.V114.22.592.592

Published: 2009

Journal Articles

The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragment

Jae Jin Chae, Geryl Wood, Katharina Richard, Howard Jaffe, Nona T. Colburn, Seth L. Masters, Deborah L. Gumucio, Nitza G. Shoham, Daniel L. Kastner

Blood (2008) 112 (5): 1794–1803.

https://doi.org/10.1182/blood-2008-01-134932

Published: 2008

Includes: Supplemental data

Journal Articles

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome

Evelien J. Bodar, Jeroen C.H. van der Hilst, Waander van Heerde, Jos W. M. van der Meer, Joost P. H. Drenth, Anna Simon

Blood (2006) 109 (6): 2416–2418.

https://doi.org/10.1182/blood-2005-10-039578

Published: 2006

Journal Articles

Genetic Screening of Familial Mediterranean Fever in Japan.

Yasuko Miyahara, MD, PhD, Kouhei Yamashita, MD PHD, Takashi Miyoshi, MD, Akifumi Takaori, MD PHD, Masataka Sasada, MD PHD, Takashi Uchiyama, MD PHD

Blood (2006) 108 (11): 3846.

https://doi.org/10.1182/blood.V108.11.3846.3846

Published: 2006

Journal Articles

Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)

Adrian A. Lobito, Fiona C. Kimberley, Jagan R. Muppidi, Hirsh Komarow, Adrianna J. Jackson, Keith M. Hull, Daniel L. Kastner, Gavin R. Screaton, Richard M. Siegel

Blood (2006) 108 (4): 1320–1327.

https://doi.org/10.1182/blood-2005-11-006783

Published: 2006

Includes: Supplemental data

Journal Articles

Fahrenheit 18 E3

Helene F. Rosenberg

Blood (2006) 107 (8): 3020–3021.

https://doi.org/10.1182/blood-2006-01-0411

Published: 2006

Journal Articles

Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever

Isabelle Touitou, Eldad Ben-Chetrit, Ruth Gershoni-Baruch, Gilles Grateau, Daniel L. Kastner, Isabelle Kone-Paut, Avi Livneh, Raffaele Manna, Issam Mansour, Huri Ozdogan, Seza Ozen, Tamara Sarkisian, Mehmet Tunca, Fatos Yalcinkaya

Blood (2003) 102 (1): 409.

https://doi.org/10.1182/blood-2003-04-1105

Published: 2003

Journal Articles

Should patients with FMF undergo BMT?

Isabelle Touitou

Blood (2003) 101 (3): 1205.

https://doi.org/10.1182/blood-2002-10-3066

Published: 2003

Journal Articles

Allogeneic bone marrow transplantation: cure for familial Mediterranean fever

John Milledge, Peter J. Shaw, Albert Mansour, Sarah Williamson, Bruce Bennetts, Tony Roscioli, Julie Curtin, John Christodoulou

Blood (2002) 100 (3): 774–777.

https://doi.org/10.1182/blood-2002-02-0651

Published: 2002

Journal Articles

The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments

Elizabeth Mansfield, Jae Jin Chae, Hirsh D. Komarow, Tilmann M. Brotz, David M. Frucht, Ivona Aksentijevich, Daniel L. Kastner

Blood (2001) 98 (3): 851–859.

https://doi.org/10.1182/blood.V98.3.851

Published: 2001

Journal Articles

Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures

Yaacov Matzner, Suzan Abedat, Eli Shapiro, Shlomit Eisenberg, Ariela Bar-Gil-Shitrit, Polina Stepensky, Sima Calco, Yehudit Azar, Simcha Urieli-Shoval

Blood (2000) 96 (2): 727–731.

https://doi.org/10.1182/blood.V96.2.727

Published: 2000

Journal Articles

The gene for familial Mediterranean fever, MEFV , is expressed in early leukocyte development and is regulated in response to inflammatory mediators

Michael Centola, Geryl Wood, David M. Frucht, Jerome Galon, Martin Aringer, Christopher Farrell, Douglas W. Kingma, Mitchell E. Horwitz, Elizabeth Mansfield, Steven M. Holland, John J. O'Shea, Helene F. Rosenberg, Harry L. Malech, Daniel L. Kastner

Blood (2000) 95 (10): 3223–3231.

https://doi.org/10.1182/blood.V95.10.3223

Published: 2000

Journal Articles

Hematopoietic-specific expression of MEFV , the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin

Nicola Tidow, Xiaoguang Chen, Carsten Müller, Seiji Kawano, Adrian F. Gombart, Nathan Fischel-Ghodsian, H. Phillip Koeffler

Blood (2000) 95 (4): 1451–1455.

https://doi.org/10.1182/blood.V95.4.1451.004k52_1451_1455

Published: 2000

NARROW

CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

A Two-Site Interaction Underpins TRIM25 Activation of the RIG-I Anti-Viral Response

Response Of Rare Variants Of Cutaneous T Cell Lymphoma (CTCL) To Treatment With Bexarotene. A Prospective German DeCOG Trial

Mutations in the TNFRSF1A, CEBPE and ELANE genes in a Congenital Cyclic Neutropenia Patient: A New Syndrome?

Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL.

The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragment

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome

Genetic Screening of Familial Mediterranean Fever in Japan.

Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)

Fahrenheit 18 E3

Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever

Should patients with FMF undergo BMT?

Allogeneic bone marrow transplantation: cure for familial Mediterranean fever

The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments

Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures

The gene for familial Mediterranean fever, MEFV , is expressed in early leukocyte development and is regulated in response to inflammatory mediators

Hematopoietic-specific expression of MEFV , the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only